UPDATE : Friday, December 6, 2019
상단여백
SK Biopharm set to ensure superiority in antiepileptic drug
SK Biopharmaceuticals said it would begin to develop a second new drug for ...
by Jeong Sae-im  |  2019-12-04 16:18
라인
Samyang Biopharm’s US subsidiary to work on new immunotherapy
Samyang Biopharm USA said Tuesday it has signed a deal to adopt a new immun...
by Jeong Sae-im  |  2019-12-03 15:37
라인
Alteogen inks licensing-out deal for SC injection formulation technology
Alteogen, a biotech firm, said it has successfully concluded a deal to make...
by Jeong Sae-im  |  2019-12-02 15:25
라인
Daewoong challenges gastric acid blocker K-Cab with Fexuprazan
Daewoong Pharmaceutical said its new drug Fexuprazan will challenge the pot...
by Jeong Sae-im  |  2019-11-29 15:23
라인
New Parkinson’s drug Ongentys lands on Korea
SK Chemicals said Thursday it has won local marketing license for Ongentys ...
by Jeong Sae-im  |  2019-11-28 14:52
라인
Kolon Life Science’s research head arrested for false Invossa data
A Seoul court issued an arrest warrant for an executive at Kolon Life Scien...
by Jeong Sae-im  |  2019-11-28 11:18
라인
SK Chemicals wins FDA nod for patch-type Alzheimer’s drug
SK Chemicals said it has obtained approval from the U.S. Food and Drug Admi...
by Jeong Sae-im  |  2019-11-27 18:24
라인
Roche Diagnostics challenges IBM Watson with differentiated strategy in tailor-made treatment market
Roche Diagnostics Korea rolled out NAVIFY Tumor Board, a data integration p...
by Jeong Sae-im  |  2019-11-21 15:48
라인
Oncologists vow to fight cancer through precision medicine
“We will build big data through Korean Precision Medicine Networking Group ...
by Jeong Sae-im  |  2019-11-21 14:28
라인
Vivozon’s acquisition of Lumimicro may aim at backdoor listing
Vivozon, a privately held biopharmaceutical firm on the over-the-counter (O...
by Jeong Sae-im  |  2019-11-20 14:44
라인
PharmAbcine registers 1st patient for phase-2 trial on olinvacimab
PharmAbcine, a developer of antibody drugs, said it has registered the firs...
by Jeong Sae-im  |  2019-11-19 17:18
라인
‘New law needed to curb rising chronic kidney disease’
A lawmaker and physicians have voiced for enacting new legislation to conta...
by Jeong Sae-im  |  2019-11-19 11:45
라인
‘Udenafil improved exercise in single ventricle heart disease’
Mezzion Pharma said its investigational drug udenafil improved exercise cap...
by Jeong Sae-im  |  2019-11-18 14:48
라인
Prosecutors raid drugmakers, distributors for suspected bid-rigging
Prosecutors have begun investigating local drug companies and distributors ...
by Jeong Sae-im  |  2019-11-14 15:27
라인
How can Korean drugmakers enter Europe successfully?
Officials from the Korea Pharmaceutical and Bio-Pharma Manufacturers Associ...
by Jeong Sae-im  |  2019-11-13 15:22
라인
Samsung Bioepis expects ₩1 trillion biosimilar sales this year
Samsung Bioepis said it was confident of achieving 1 trillion won ($855.8 m...
by Jeong Sae-im  |  2019-11-13 15:21
라인
[News Focus] ‘FDA could allow resumption of Invossa trial’
Amid the prosecution’s probe into Kolon Life Science’s osteoarthritis gene ...
by Jeong Sae-im  |  2019-11-12 15:48
라인
Eunpyeong St. Mary’s Hospital adopts AI nursing documentation
The Catholic University of Korea Eunpyeong St. Mary’s Hospital said Tuesday...
by Jeong Sae-im  |  2019-11-12 15:47
라인
Genexine’s new immunotherapy shows stability even in high dose
GX-I7, a new immunotherapy candidate being developed jointly by Genexine an...
by Jeong Sae-im  |  2019-11-11 13:36
라인
‘Cancer patients suffered side effects after taking anthelmintic drug’
Some cancer patients took a deworming medicine to cure their disease but su...
by Jeong Sae-im  |  2019-11-08 13:30
여백
여백
여백
Back to Top